Joseph Konowiecki Sells 25,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) EVP Joseph Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $23.00, for a total transaction of $575,000.00. Following the sale, the executive vice president owned 1,128,816 shares in the company, valued at approximately $25,962,768. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Trading Up 2.2%

Shares of NASDAQ ALHC opened at $23.21 on Friday. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The firm has a 50 day moving average price of $18.76 and a two-hundred day moving average price of $19.58. The stock has a market cap of $4.80 billion, a P/E ratio of 257.84, a price-to-earnings-growth ratio of 3.13 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The company’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.05) earnings per share. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ALHC. Zacks Research raised Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Barclays lowered their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Finally, UBS Group raised their price target on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $24.30.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Hudson Bay Capital Management LP acquired a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $4,581,000. 1492 Capital Management LLC grew its holdings in Alignment Healthcare by 61.8% in the fourth quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock worth $6,416,000 after purchasing an additional 124,143 shares during the period. Vanguard Group Inc. increased its stake in Alignment Healthcare by 5.0% in the third quarter. Vanguard Group Inc. now owns 13,968,584 shares of the company’s stock valued at $243,752,000 after purchasing an additional 664,769 shares in the last quarter. Cinctive Capital Management LP bought a new stake in Alignment Healthcare in the third quarter valued at $3,814,000. Finally, William Blair Investment Management LLC raised its holdings in shares of Alignment Healthcare by 43.4% during the third quarter. William Blair Investment Management LLC now owns 2,119,952 shares of the company’s stock valued at $36,993,000 after purchasing an additional 641,381 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.